These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24041477)

  • 21. [Homozygous familial hypercholesterolemia].
    Kaylkçioğlu M
    Turk Kardiyol Dern Ars; 2014 Oct; 42 Suppl 2():19-31. PubMed ID: 25693360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Familial hypercholesterolaemia: a review with emphasis on evidence for treatment, new models of care and health economic evaluations.
    Watts GF; Juniper A; van Bockxmeer F; Ademi Z; Liew D; O'Leary P
    Int J Evid Based Healthc; 2012 Sep; 10(3):211-21. PubMed ID: 22925618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guidelines for the identification and management of patients with familial hypercholesterolaemia (FH): are we coming to a consensus?
    Humphries SE
    Atheroscler Suppl; 2011 Oct; 12(2):217-20. PubMed ID: 22230092
    [No Abstract]   [Full Text] [Related]  

  • 24. Canadian Cardiovascular Society position statement on familial hypercholesterolemia.
    ; Genest J; Hegele RA; Bergeron J; Brophy J; Carpentier A; Couture P; Davignon J; Dufour R; Frohlich J; Gaudet D; Gupta M; Krisnamoorthy P; Mancini J; McCrindle B; Raggi P; Ruel I; St-Pierre J
    Can J Cardiol; 2014 Dec; 30(12):1471-81. PubMed ID: 25448461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are patients with familial hypercholesterolaemia well managed in lipid clinics? An audit of eleven clinics from the Department of Health Familial Hypercholesterolaemia Cascade Testing project.
    Hadfield SG; Horara S; Starr BJ; Yazdgerdi S; Bhatnagar D; Cramb R; Egan S; Everdell R; Ferns G; Jones A; Marenah CB; Marples J; Prinsloo P; Sneyd A; Stewart MF; Sandle L; Wang T; Watson MS; Humphries SE
    Ann Clin Biochem; 2008 Mar; 45(Pt 2):199-205. PubMed ID: 18325186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Landmark position paper on paediatric familial hypercholesterolaemia from the EAS Consensus Panel.
    Stock J
    Atherosclerosis; 2015 Sep; 242(1):277-80. PubMed ID: 26232168
    [No Abstract]   [Full Text] [Related]  

  • 27. Optimising the detection and management of familial hypercholesterolaemia: central role of primary care and its integration with specialist services.
    Vickery AW; Bell D; Garton-Smith J; Kirke AB; Pang J; Watts GF
    Heart Lung Circ; 2014 Dec; 23(12):1158-64. PubMed ID: 25130889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Essence of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan-2012 Version and Treatment Guide for Dyslipidemia 2013--Current Strategy for the Lipid Assessment].
    Arai H
    Rinsho Byori; 2014 Sep; 62(9):878-83. PubMed ID: 27526533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The efficacy of colesevelam HCl in the treatment of heterozygous familial hypercholesterolemia in pediatric and adult patients.
    Davidson M
    Clin Ther; 2013 Aug; 35(8):1247-52. PubMed ID: 23916045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recommendations for the management of patients with familial hypercholesterolemia.
    Feldman DI; Blaha MJ; Santos RD; Jones SR; Blumenthal RS; Toth PP; Sperling LS; Martin SS
    Curr Atheroscler Rep; 2015 Jan; 17(1):473. PubMed ID: 25404096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Early diagnosis of familial hypercholesterolemia in Czech Republic in pursuance of MedPed Project].
    Freiberger T; Vrablík M
    Vnitr Lek; 2015 Nov; 61(11):942-5. PubMed ID: 26652781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Is detection and treatment of familial hypercholesterolemia indicated in children?].
    Bakker HD; Wiegman A; Defesche JC; Kastelein JJ
    Ned Tijdschr Geneeskd; 1997 Dec; 141(52):2548-51. PubMed ID: 9555154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Familial hypercholesterolemia in children and adolescents: A clinical perspective.
    de Ferranti SD
    J Clin Lipidol; 2015; 9(5 Suppl):S11-9. PubMed ID: 26343208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic, clinical, and therapeutic aspects of familial hypercholesterolemia in children.
    Ose L
    Semin Vasc Med; 2004 Feb; 4(1):51-7. PubMed ID: 15199433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defining the role of lipoprotein apheresis in the management of familial hypercholesterolemia.
    Lee WP; Datta BN; Ong BB; Rees A; Halcox J
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):363-70. PubMed ID: 22149315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Familial hypercholesterolemia in Spain: case-finding program, clinical and genetic aspects.
    Pocovi M; Civeira F; Alonso R; Mata P
    Semin Vasc Med; 2004 Feb; 4(1):67-74. PubMed ID: 15199435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia: A Global Call to Action.
    ; Wilemon KA; Patel J; Aguilar-Salinas C; Ahmed CD; Alkhnifsawi M; Almahmeed W; Alonso R; Al-Rasadi K; Badimon L; Bernal LM; Bogsrud MP; Braun LT; Brunham L; Catapano AL; Cillíková K; Corral P; Cuevas R; Defesche JC; Descamps OS; de Ferranti S; Eiselé JL; Elikir G; Folco E; Freiberger T; Fuggetta F; Gaspar IM; Gesztes ÁG; Grošelj U; Hamilton-Craig I; Hanauer-Mader G; Harada-Shiba M; Hastings G; Hovingh GK; Izar MC; Jamison A; Karlsson GN; Kayikçioglu M; Koob S; Koseki M; Lane S; Lima-Martinez MM; López G; Martinez TL; Marais D; Marion L; Mata P; Maurina I; Maxwell D; Mehta R; Mensah GA; Miserez AR; Neely D; Nicholls SJ; Nohara A; Nordestgaard BG; Ose L; Pallidis A; Pang J; Payne J; Peterson AL; Popescu MP; Puri R; Ray KK; Reda A; Sampietro T; Santos RD; Schalkers I; Schreier L; Shapiro MD; Sijbrands E; Soffer D; Stefanutti C; Stoll M; Sy RG; Tamayo ML; Tilney MK; Tokgözoglu L; Tomlinson B; Vallejo-Vaz AJ; Vazquez-Cárdenas A; de Luca PV; Wald DS; Watts GF; Wenger NK; Wolf M; Wood D; Zegerius A; Gaziano TA; Gidding SS
    JAMA Cardiol; 2020 Feb; 5(2):217-229. PubMed ID: 31895433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel pharmacotherapies of familial hyperlipidemia.
    Drakopoulou M; Toutouzas K; Stefanadis C
    Pharmacol Ther; 2013 Sep; 139(3):301-12. PubMed ID: 23639874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic aspects of familial hypercholesterolemia and its diagnosis.
    Motulsky AG
    Arteriosclerosis; 1989; 9(1 Suppl):I3-7. PubMed ID: 2563220
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of familial heterozygous hypercholesterolemia: Position Paper of the Polish Lipid Expert Forum.
    Rynkiewicz A; Cybulska B; Banach M; Filipiak K; Guzik T; Idzior-Waluś B; Imiela J; Jankowski P; Kłosiewicz-Latoszek L; Limon J; Myśliwiec M; Opolski G; Steciwko A; Stępińska J; Zdrojewski T
    J Clin Lipidol; 2013; 7(3):217-21. PubMed ID: 23725921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.